These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Novel synthesized SLC-0111 thiazole and thiadiazole analogues: Determination of their carbonic anhydrase inhibitory activity and molecular modeling studies. Abo-Ashour MF; Eldehna WM; Nocentini A; Ibrahim HS; Bua S; Abdel-Aziz HA; Abou-Seri SM; Supuran CT Bioorg Chem; 2019 Jun; 87():794-802. PubMed ID: 30978604 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of sulfonamides incorporating piperazinyl-ureido moieties and their carbonic anhydrase I, II, IX and XII inhibitory activity. Congiu C; Onnis V; Deplano A; Balboni G; Dedeoglu N; Supuran CT Bioorg Med Chem Lett; 2015 Sep; 25(18):3850-3. PubMed ID: 26233435 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and carbonic anhydrase inhibition of a series of SLC-0111 analogs. Carta F; Vullo D; Osman SM; AlOthman Z; Supuran CT Bioorg Med Chem; 2017 May; 25(9):2569-2576. PubMed ID: 28347633 [TBL] [Abstract][Full Text] [Related]
7. Novel benzofuran-based sulphonamides as selective carbonic anhydrases IX and XII inhibitors: synthesis and Abdelrahman MA; Eldehna WM; Nocentini A; Ibrahim HS; Almahli H; Abdel-Aziz HA; Abou-Seri SM; Supuran CT J Enzyme Inhib Med Chem; 2020 Dec; 35(1):298-305. PubMed ID: 31809607 [TBL] [Abstract][Full Text] [Related]
8. Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: Selective inhibitors for the tumor-associated hCA IX isoform. Ibrahim HS; Allam HA; Mahmoud WR; Bonardi A; Nocentini A; Gratteri P; Ibrahim ES; Abdel-Aziz HA; Supuran CT Eur J Med Chem; 2018 May; 152():1-9. PubMed ID: 29684705 [TBL] [Abstract][Full Text] [Related]
9. 1,3-Diaryl Triazenes Incorporating Disulfonamides Show Both Antiproliferative Activity and Effective Inhibition of Tumor-associated Carbonic Anhydrases IX and XII. Lolak N; Akocak S; Petreni A; Budak Y; Bozgeyik E; Gurdere MB; Ceylan M; Supuran CT Anticancer Agents Med Chem; 2024; 24(10):755-763. PubMed ID: 38362678 [TBL] [Abstract][Full Text] [Related]
11. Iodoquinazolinones bearing benzenesulfonamide as human carbonic anhydrase I, II, IX and XII inhibitors: Synthesis, biological evaluation and radiosensitizing activity. Soliman AM; Ghorab MM; Bua S; Supuran CT Eur J Med Chem; 2020 Aug; 200():112449. PubMed ID: 32485534 [TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII. Sławiński J; Szafrański K; Vullo D; Supuran CT Eur J Med Chem; 2013 Nov; 69():701-10. PubMed ID: 24095761 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of novel carbohydrate-based sulfonamide derivatives as antitumor agents. Hao S; Cheng X; Wang X; An R; Xu H; Guo M; Li C; Wang Y; Hou Z; Guo C Bioorg Chem; 2020 Nov; 104():104237. PubMed ID: 32911194 [TBL] [Abstract][Full Text] [Related]
15. Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies. Żołnowska B; Sławiński J; Szafrański K; Angeli A; Supuran CT; Kawiak A; Wieczór M; Zielińska J; Bączek T; Bartoszewska S Eur J Med Chem; 2018 Jan; 143():1931-1941. PubMed ID: 29146134 [TBL] [Abstract][Full Text] [Related]
16. Anticancer effects of new dibenzenesulfonamides by inducing apoptosis and autophagy pathways and their carbonic anhydrase inhibitory effects on hCA I, hCA II, hCA IX, hCA XII isoenzymes. Gul HI; Yamali C; Bulbuller M; Kirmizibayrak PB; Gul M; Angeli A; Bua S; Supuran CT Bioorg Chem; 2018 Aug; 78():290-297. PubMed ID: 29621641 [TBL] [Abstract][Full Text] [Related]
17. Sulfonamide-based ring-fused analogues for CAN508 as novel carbonic anhydrase inhibitors endowed with antitumor activity: Design, synthesis, and in vitro biological evaluation. Said MA; Eldehna WM; Nocentini A; Fahim SH; Bonardi A; Elgazar AA; Kryštof V; Soliman DH; Abdel-Aziz HA; Gratteri P; Abou-Seri SM; Supuran CT Eur J Med Chem; 2020 Mar; 189():112019. PubMed ID: 31972394 [TBL] [Abstract][Full Text] [Related]
18. Application of the dual-tail approach for the design and synthesis of novel Thiopyrimidine-Benzenesulfonamide hybrids as selective carbonic anhydrase inhibitors. Abdel-Mohsen HT; El Kerdawy AM; Omar MA; Petreni A; Allam RM; El Diwani HI; Supuran CT Eur J Med Chem; 2022 Jan; 228():114004. PubMed ID: 34847409 [TBL] [Abstract][Full Text] [Related]
19. New anticancer drug candidates sulfonamides as selective hCA IX or hCA XII inhibitors. Gul HI; Yamali C; Sakagami H; Angeli A; Leitans J; Kazaks A; Tars K; Ozgun DO; Supuran CT Bioorg Chem; 2018 Apr; 77():411-419. PubMed ID: 29427856 [TBL] [Abstract][Full Text] [Related]
20. Synthesis, biological evaluation and in silico modelling studies of 1,3,5-trisubstituted pyrazoles carrying benzenesulfonamide as potential anticancer agents and selective cancer-associated hCA IX isoenzyme inhibitors. Yamali C; Gul HI; Ece A; Bua S; Angeli A; Sakagami H; Sahin E; Supuran CT Bioorg Chem; 2019 Nov; 92():103222. PubMed ID: 31499260 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]